Application Nr Approved Date Route Status External Links
ANDA077750 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Cabergoline Tablets Are Indicated For The Treatment Of Hyperprolactinemic Disorders, Either Idiopathic Or Due To Pituitary Adenomas.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Cabergoline CABERGOLINE ZINC3800008

Comments